RxDoctor Payments Data

Julie Keller, MD

Orthopaedic Trauma · Maywood, NJNPI 1619134285

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $21,399 of the $29,107 with a category attached, or 73.5%. 15 manufacturers reported payments, led by Stryker at 56.2% of the total. Reporting peaked in 2022 at $8,450 and has fallen 97.1% since, to $249 in 2025.

$29,107in general payments, 2019–2025

Across 55 payments — averaging $529.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$16K
  • Synthes USA Products LLC$7K
  • Synthes GmbH$5K
  • Medical Device Business Services, Inc.$900
  • Fusion Orthopedics USA, LLC$128
  • Johnson & Johnson$124
  • plus $359 from 9 others

What the payments were for

  • Consulting fees$21,39974%
  • Speaking & faculty fees$3,00010%
  • Travel & lodging$2,6999%
  • Food & beverage$2,0087%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few orthopaedic trauma providers in New Jerseyto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$103,455
Medicare patients
172
Services billed
500

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib17$366

Paid to pharmacies, not to this prescriber.

Other orthopaedic trauma in Maywood

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →